Diagnosis and management of acute iron poisoning. 1989

L G Reynolds

All children who ingest iron tablets accidentally are at risk of severe, possibly fatal, poisoning. Death in the first stage of acute iron poisoning is due to hypovolaemic shock; in the third stage it is due to widespread cellular dysfunction as a result of mitochondrial disruption caused by intracellular iron. It appears that once a critical amount of iron has reached the mitochondria therapy has little effect and the outcome is poor. Rational therapy must be started without delay. The crucial aspect of early management is to remove as much iron as possible from the intestine before absorption and tissue uptake can occur. The aims of parenteral chelation therapy are to prevent iron in the extracellular fluid from entering the cells and to protect the mitochondria from iron already in the cells. An effective circulating blood volume must be maintained. Iron poisoning occurs predominantly in areas where iron is given routinely to mothers during pregnancy without sufficient regard for its potentially lethal effects on toddlers. Child-proof packaging is the single most effective way to prevent iron poisoning but it is expensive and not practical in poor countries. Iron prophylaxis in pregnancy should be routine only in areas where a high prevalence of iron deficiency justifies it. It should be accompanied by education of the public, pharmacists, nurses and doctors.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007501 Iron A metallic element with atomic symbol Fe, atomic number 26, and atomic weight 55.85. It is an essential constituent of HEMOGLOBINS; CYTOCHROMES; and IRON-BINDING PROTEINS. It plays a role in cellular redox reactions and in the transport of OXYGEN. Iron-56,Iron 56
D008297 Male Males
D002614 Chelating Agents Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. Chelating Agent,Chelator,Complexons,Metal Antagonists,Chelators,Metal Chelating Agents,Agent, Chelating,Agents, Chelating,Agents, Metal Chelating,Antagonists, Metal,Chelating Agents, Metal
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003676 Deferoxamine Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form. Desferrioxamine,Deferoxamine B,Deferoxamine Mesilate,Deferoxamine Mesylate,Deferoxamine Methanesulfonate,Deferoximine,Deferrioxamine B,Desferal,Desferioximine,Desferrioxamine B,Desferrioxamine B Mesylate,Desferroxamine,Mesilate, Deferoxamine,Mesylate, Deferoxamine,Mesylate, Desferrioxamine B,Methanesulfonate, Deferoxamine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

L G Reynolds
January 1986, Medical toxicology,
L G Reynolds
April 1965, British medical journal,
L G Reynolds
March 1965, British medical journal,
L G Reynolds
June 2003, Indian pediatrics,
L G Reynolds
November 1974, Anaesthesia and intensive care,
L G Reynolds
May 2009, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies,
L G Reynolds
October 1979, Clinical pediatrics,
L G Reynolds
March 1969, The Medical journal of Australia,
L G Reynolds
May 1982, The Journal of pediatrics,
L G Reynolds
July 1971, American journal of diseases of children (1960),
Copied contents to your clipboard!